US20060216313A1
(en)
*
|
1999-08-10 |
2006-09-28 |
Allergan, Inc. |
Methods for treating a stricture with a botulinum toxin
|
US7838008B2
(en)
*
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
US7691983B2
(en)
|
2000-07-21 |
2010-04-06 |
Allergan, Inc. |
Chimera botulinum toxin type E
|
US20040219619A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Ester Fernandez-Salas |
Methods of identifying compounds that alter toxin persistence and/or protease activity
|
US7491799B2
(en)
*
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
US6423319B1
(en)
*
|
2000-10-04 |
2002-07-23 |
Allergan Sales, Inc. |
Methods for treating muscle injuries
|
ITUD20010002A1
(it)
*
|
2001-01-05 |
2002-07-05 |
Univ Degli Studi Udine |
Uso della tossina botulinica per la soluzione di patologie articolari, in particolare della coxartrosi, della epicondilite e della patolo
|
JP4707254B2
(ja)
*
|
2001-04-24 |
2011-06-22 |
クミアイ化学工業株式会社 |
粒状組成物及びその製造方法
|
WO2003000193A2
(en)
*
|
2001-06-21 |
2003-01-03 |
Surromed, Inc. |
Covalent coupling of botulinum toxin with polyethylene glycol
|
AU2002348370B8
(en)
|
2001-11-15 |
2008-05-01 |
Micro Algae Corporation |
Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
|
US7140371B2
(en)
*
|
2002-03-14 |
2006-11-28 |
Allergan, Inc. |
Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
|
US7300412B2
(en)
*
|
2002-05-10 |
2007-11-27 |
Hospital For Joint Diseases |
Methods for therapeutic treatment of carpal tunnel syndrome
|
EP1539152A4
(de)
*
|
2002-08-02 |
2006-10-18 |
Nutraceutical Dev Corp |
ENTWICKLUNG DER MUSKELMASSE IN EINEM SûUGETIER
|
US20040037895A1
(en)
*
|
2002-08-23 |
2004-02-26 |
Alex Zhu |
Methods of treating involuntary facial spasms and facial wrinkles
|
BR0315319A
(pt)
*
|
2002-10-15 |
2005-08-16 |
Allergan Inc |
Terapias e procedimentos dentais com toxina botulìnica
|
US7238357B2
(en)
*
|
2002-11-05 |
2007-07-03 |
Allergan, Inc. |
Methods for treating ulcers and gastroesophageal reflux disease
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
MXPA05009425A
(es)
*
|
2003-03-06 |
2006-02-10 |
Botulinum Toxin Res Ass Inc |
Tratamiento del dolor facial cronico y cefalea relacionados con la sinusitis con toxina botulinica.
|
US7393538B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Ackerman Alan H |
Clostridial toxin treatment for dermatillomania
|
US7422753B2
(en)
*
|
2003-04-25 |
2008-09-09 |
Allergan, Inc. |
Methods for treating trichotillomania
|
US7390496B2
(en)
*
|
2003-04-25 |
2008-06-24 |
Allergan, Inc. |
Therapeutic treatments for repetitive hand washing
|
US7393537B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Allergan, Inc. |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder
|
US7396535B2
(en)
*
|
2003-04-25 |
2008-07-08 |
Ackerman Alan H |
Therapy for obsessive compulsive head banging
|
US6838434B2
(en)
*
|
2003-05-02 |
2005-01-04 |
Allergan, Inc. |
Methods for treating sinus headache
|
US7220422B2
(en)
*
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
US20040253274A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Allergan, Inc. |
Use of a clostridial toxin to reduce appetite
|
US20050013850A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Caers Jan K. |
Device to assist hyperhydrosis therapy
|
WO2006096164A1
(en)
|
2005-03-03 |
2006-09-14 |
Allergan, Inc. |
Media for clostridium bacterium and processes for obtaining a clostridial toxin
|
US8609112B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
US8617572B2
(en)
|
2003-10-29 |
2013-12-31 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
US8609113B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
US8734810B2
(en)
*
|
2003-10-29 |
2014-05-27 |
Allergan, Inc. |
Botulinum toxin treatments of neurological and neuropsychiatric disorders
|
US7172764B2
(en)
*
|
2003-11-17 |
2007-02-06 |
Allergan, Inc. |
Rescue agents for treating botulinum toxin intoxications
|
US8871224B2
(en)
|
2003-12-09 |
2014-10-28 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
US8048423B2
(en)
*
|
2003-12-09 |
2011-11-01 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
US20050129677A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Shengwen Li |
Lipid rafts and clostridial toxins
|
US20050148935A1
(en)
*
|
2003-12-29 |
2005-07-07 |
Rozalina Dimitrova |
Botulinum toxin injection guide
|
US7270287B2
(en)
*
|
2004-01-06 |
2007-09-18 |
Allergan, Inc. |
Botulinum toxin treatment for kinesia
|
US6974579B2
(en)
*
|
2004-01-08 |
2005-12-13 |
Allergan, Inc. |
Methods for treating vascular disorders
|
US20050191321A1
(en)
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
US9078892B2
(en)
*
|
2004-02-26 |
2015-07-14 |
Allergan, Inc. |
Methods for treating pain and for treating a medication overuse disorder
|
US20100266638A1
(en)
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
US20050220821A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Allergan, Inc. |
Pressure sore treatment
|
US20050220734A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Allergan, Inc. |
Therapy for melanin related afflictions
|
BRPI0510760A
(pt)
*
|
2004-05-07 |
2007-11-20 |
Phytotox Ltd |
método para administrar a um paciente uma composição, composição tópica, e, emplastro
|
MXPA06012962A
(es)
*
|
2004-05-07 |
2007-06-12 |
Phytotox Ltd |
Metodos para el tratamiento de heridas con gonyautoxinas.
|
US6991789B2
(en)
*
|
2004-06-29 |
2006-01-31 |
Allergas, Inc. |
Methods of modulating intracellular degradation rates of toxins
|
US7514088B2
(en)
*
|
2005-03-15 |
2009-04-07 |
Allergan, Inc. |
Multivalent Clostridial toxin derivatives and methods of their use
|
US7811584B2
(en)
*
|
2004-06-30 |
2010-10-12 |
Allergan, Inc. |
Multivalent clostridial toxins
|
US7922983B2
(en)
*
|
2005-07-28 |
2011-04-12 |
Kimberly-Clark Worldwide, Inc. |
Sterilization wrap with additional strength sheet
|
US20060024794A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Shengwen Li |
Novel methods for production of di-chain botulinum toxin
|
US20060024331A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Ester Fernandez-Salas |
Toxin compounds with enhanced membrane translocation characteristics
|
JP5089388B2
(ja)
|
2004-09-01 |
2012-12-05 |
アラーガン、インコーポレイテッド |
分解可能なクロストリジウム毒素
|
US7429386B2
(en)
*
|
2004-09-03 |
2008-09-30 |
Allergan, Inc. |
Stretch mark treatment
|
US7179474B2
(en)
*
|
2004-09-03 |
2007-02-20 |
Allergan, Inc. |
Methods for treating a buttock deformity
|
US20060073208A1
(en)
*
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
US7897147B2
(en)
*
|
2004-10-20 |
2011-03-01 |
Allergan, Inc. |
Treatment of premenstrual disorders
|
US7749515B2
(en)
|
2005-02-01 |
2010-07-06 |
Allergan, Inc. |
Targeted delivery of botulinum toxin to the sphenopalatine ganglion
|
US7655244B2
(en)
|
2005-02-01 |
2010-02-02 |
Allergan, Inc. |
Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
|
WO2006101809A1
(en)
|
2005-03-15 |
2006-09-28 |
Allergan, Inc. |
Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
|
DE602006017237D1
(en)
|
2005-04-05 |
2010-11-11 |
Allergan Inc |
Clostridientoxinaktivitätstests
|
US7419675B2
(en)
*
|
2005-05-26 |
2008-09-02 |
Allergan, Inc. |
Method for treating peritoneal adhesions
|
WO2006129171A2
(en)
*
|
2005-05-31 |
2006-12-07 |
Polydoor Emile Huijsmans |
Method and medical package for repairing tendons by surgery
|
US20060269574A1
(en)
*
|
2005-05-31 |
2006-11-30 |
De Beer Johann F |
Method of repairing tendons by surgery
|
US8105611B2
(en)
|
2005-06-17 |
2012-01-31 |
Allergan, Inc. |
Treatment of autoimmune disorder with a neurotoxin
|
US7910116B2
(en)
*
|
2005-08-24 |
2011-03-22 |
Allergan, Inc. |
Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
|
US7824694B2
(en)
*
|
2006-01-12 |
2010-11-02 |
Allergan, Inc. |
Methods for enhancing therapeutic effects of a neurotoxin
|
US20070178121A1
(en)
*
|
2006-01-27 |
2007-08-02 |
Allergan, Inc. |
Methods for enhancing skin treatments
|
US7794386B2
(en)
|
2006-03-15 |
2010-09-14 |
Allergan, Inc. |
Methods for facilitating weight loss
|
US7811586B2
(en)
*
|
2006-05-02 |
2010-10-12 |
Allergan, Inc. |
Methods for alleviating testicular pain
|
CN101074935B
(zh)
*
|
2006-05-19 |
2011-03-23 |
清华大学 |
探测器阵列及设备
|
US9061025B2
(en)
*
|
2006-08-31 |
2015-06-23 |
Allergan, Inc. |
Methods for selecting headache patients responsive to botulinum toxin therapy
|
US20080092910A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Allergan, Inc. |
Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures
|
US20080113051A1
(en)
*
|
2006-11-13 |
2008-05-15 |
Allergan, Inc. |
Methods for alleviating tattoo pain
|
ES2520765T3
(es)
*
|
2007-02-15 |
2014-11-11 |
Allergan, Inc. |
Uso de toxina botulínica para el tratamiento de hiperhidrosis
|
US8470337B2
(en)
*
|
2008-03-13 |
2013-06-25 |
Allergan, Inc. |
Therapeutic treatments using botulinum neurotoxin
|
US8617571B2
(en)
|
2008-04-03 |
2013-12-31 |
Allergan, Inc. |
Suture line administration technique using botulinum toxin
|
ES2356883B1
(es)
*
|
2008-07-24 |
2012-02-22 |
Bcn Peptides, S.A. |
Composición para el tratamiento del dolor y/o la inflamación.
|
US20100028385A1
(en)
*
|
2008-08-04 |
2010-02-04 |
Allergan, Inc. |
Treatment of excess cerumen secretion
|
AU2010204445B2
(en)
|
2009-01-07 |
2015-09-03 |
2405871 Ontario Inc. |
Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
|
WO2010101968A1
(en)
|
2009-03-06 |
2010-09-10 |
Allergan, Inc. |
Clostridial toxin to improve ejaculate
|
EP2480250B1
(de)
|
2009-09-24 |
2014-04-16 |
Allergan, Inc. |
Zusammensetzungen Botulinumtoxin A oder B enthaltend zur Verwendung bei der Behandlung der Osteoporose
|
JP2011157331A
(ja)
*
|
2010-02-03 |
2011-08-18 |
Chemo-Sero-Therapeutic Research Inst |
高用量投与が可能なボツリヌス毒素製剤
|
WO2012103415A1
(en)
|
2011-01-28 |
2012-08-02 |
Allergan, Inc. |
Dosage regimen for the treatment of multiple disorders with botulinum toxins
|
US8697090B2
(en)
|
2011-05-05 |
2014-04-15 |
Allergan, Inc. |
Method of treating persistent genital arousal disorder with a neurotoxin
|
US8992941B2
(en)
|
2011-07-08 |
2015-03-31 |
Allergan, Inc. |
Method for treatment of esophageal spasm
|
WO2013009625A1
(en)
|
2011-07-08 |
2013-01-17 |
Allergan, Inc. |
Method for treatment of autonomic nervous system disorders
|
CN103813802A
(zh)
|
2011-07-14 |
2014-05-21 |
阿勒根公司 |
用于治疗与性活动相关的失禁的方法
|
US9138188B2
(en)
*
|
2011-07-20 |
2015-09-22 |
Joseph C. McGinley |
Method for treating and confirming diagnosis of exertional compartment syndrome
|
CN103702681A
(zh)
|
2011-07-20 |
2014-04-02 |
阿勒根公司 |
用于治疗脂肪沉积的方法
|
US9226954B2
(en)
|
2011-07-20 |
2016-01-05 |
Joseph C. McGinley |
Method for treating and confirming diagnosis of exertional compartment syndrome
|
ES2424294B1
(es)
|
2012-03-22 |
2014-07-21 |
Lipotec, S.A. |
Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
|
EP2649984A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose
|
EP2649985A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose (III)
|
ES2660901T3
(es)
|
2012-04-13 |
2018-03-26 |
Lubrizol Advanced Materials, Inc. |
Compuestos que inhiben la exocitosis neuronal (II)
|
EP2649983A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose (II)
|
US9138194B1
(en)
|
2012-06-27 |
2015-09-22 |
Joseph McGinley |
Apparatus for use to replicate symptoms associated with vascular obstruction secondary to vascular compression
|
US9005628B2
(en)
|
2012-10-04 |
2015-04-14 |
Dublin City University |
Biotherapy for pain
|
US20160045423A1
(en)
|
2013-03-22 |
2016-02-18 |
Lipotec S.A. |
Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails
|
GB201312317D0
(en)
|
2013-07-09 |
2013-08-21 |
Syntaxin Ltd |
Cationic neurotoxins
|
US10149893B2
(en)
|
2013-09-24 |
2018-12-11 |
Allergan, Inc. |
Methods for modifying progression of osteoarthritis
|
US9480731B2
(en)
|
2013-12-12 |
2016-11-01 |
Medy-Tox, Inc. |
Long lasting effect of new botulinum toxin formulations
|
US9216210B2
(en)
|
2013-12-23 |
2015-12-22 |
Dublin City University |
Multiprotease therapeutics for chronic pain
|
US10058471B2
(en)
*
|
2014-02-21 |
2018-08-28 |
William M. Vaughan |
System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries
|
EP3154572A1
(de)
*
|
2014-06-13 |
2017-04-19 |
Merz Pharma GmbH & Co. KGaA |
Neuartige verwendungen von rekombinanten clostridienneurotoxinen mit verminderter wirkungsdauer
|
US20170119863A1
(en)
*
|
2014-06-13 |
2017-05-04 |
Merz Pharma Gmbh & Co. Kgaa |
Novel uses of recombinant clostridial neurotoxins with decreased duration of effect
|
PL3242884T3
(pl)
|
2015-01-09 |
2021-08-16 |
Ipsen Bioinnovation Limited |
Kationowe neurotoksyny
|
GB201517450D0
(en)
|
2015-10-02 |
2015-11-18 |
Ipsen Biopharm Ltd |
Method
|
CN105567739B
(zh)
*
|
2016-02-04 |
2019-07-12 |
郑州可尔利尔生物科技有限公司 |
病毒载体颗粒及其构建方法和应用
|
JP2019511503A
(ja)
*
|
2016-03-25 |
2019-04-25 |
イプセン バイオファーム リミテッドIpsen Biopharm Limited |
ボツリヌス毒素の処置の効用を増強させるための理学療法情報を収集する方法
|
GB201607901D0
(en)
|
2016-05-05 |
2016-06-22 |
Ipsen Biopharm Ltd |
Chimeric neurotoxins
|
EP3263710A1
(de)
|
2016-07-01 |
2018-01-03 |
Ipsen Biopharm Limited |
Herstellung von aktivierten clostridien-neurotoxinen
|
WO2018038301A1
(en)
|
2016-08-26 |
2018-03-01 |
Hugel Inc. |
Stabilized liquid formulation of botulinum toxin and preparation method thereof
|
CN109790204A
(zh)
|
2016-09-29 |
2019-05-21 |
益普生生物制药有限公司 |
杂合神经毒素
|
WO2018106339A1
(en)
*
|
2016-12-06 |
2018-06-14 |
Bonti, Inc. |
Botulinum neurotoxins for use in tendon repair surgery
|
US20200023044A1
(en)
*
|
2017-03-22 |
2020-01-23 |
Bonti, Inc. |
Botulinum neurotoxins for treating traumatic injuries
|
EP3612213A4
(de)
*
|
2017-04-21 |
2020-12-23 |
Bonti, Inc. |
Initiierung von neurotoxin-behandlungen
|
EP3470054B1
(de)
|
2017-10-11 |
2023-09-20 |
Hugel Inc. |
Mikrostrukturformulierungstechniken für botulinumtoxin
|
US10525111B2
(en)
|
2017-10-12 |
2020-01-07 |
Hugel, Inc. |
Microstructure formulation techniques for botulinum toxin
|
US10792400B2
(en)
|
2017-10-12 |
2020-10-06 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
WO2019162696A1
(en)
|
2018-02-26 |
2019-08-29 |
Ipsen Biopharm Limited |
Use of ultrasound to guide injection of non-cytotoxic protease
|
AU2019337656A1
(en)
*
|
2018-09-13 |
2021-05-06 |
Allergan, Inc. |
Methods for treatment of masseter muscle hypertrophy
|
EP3660509B1
(de)
|
2018-11-29 |
2022-03-09 |
Hugel Inc. |
Zellbasiertes verfahren zur bestimmung der aktivität von botulinumtoxin
|
WO2020163495A1
(en)
*
|
2019-02-06 |
2020-08-13 |
Allergan, Inc. |
Combination therapy using clostridial toxin derivative and at least one chemical depolarizing agent
|
CN110710494B
(zh)
*
|
2019-10-20 |
2021-06-11 |
宋凯 |
一种眼睛王蛇毒液安全取出装置
|
JP2022040051A
(ja)
|
2020-08-27 |
2022-03-10 |
ユニテックフーズ株式会社 |
筋損傷回復促進用組成物
|
GB202103372D0
(en)
|
2021-03-11 |
2021-04-28 |
Ipsen Biopharm Ltd |
Modified clostridial neurotoxins
|
WO2024069191A1
(en)
|
2022-09-30 |
2024-04-04 |
Ipsen Biopharm Limited |
Clostridial neurotoxin for use in a treatment of bladder pain syndrome
|